Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating encouraging results in the control of type 2 diabetes. This synthetic peptide mimics the actions of naturally occurring GLP-1, a hormone that plays a crucial role in regulating blood insulin response. By enhancing website GLP-1 receptors in the pancreas, Retasturtide